Revenue recognition change
beta
Filing comparison
SUPERNUS PHARMACEUTICALS, INC. changed its revenue recognition disclosure
The Company has no contract assets as of December 31, 2025 or 2024.
Evidence
- New language
- The Company has no contract assets as of December 31, 2025 or 2024., The Company has $3.1 million of contract liabilities as of December 31, 2025, and no contract liabilities as of December 31, 2024.
- Prior filed
- 2025-02-25
- Prior form
- 10-K
- Similarity
- 0.582
- Source
- revenue recognition note comparison
- Threshold
- 0.6
- Why
- The revenue recognition policy disclosure changed materially from the previous comparable filing.
Language present now, absent from the prior filing:
- The Company has no contract assets as of December 31, 2025 or 2024.
- The Company has $3.1 million of contract liabilities as of December 31, 2025, and no contract liabilities as of December 31, 2024.